Address: 370 Convention Way, Redwood City, CA 94063
David Bradford, M.D.
Jeffrey Lotz, Ph.D.
James Peacock - CEO & Managing Member (Chairman)
Jeffrey Lotz, PhD – Chief Scientific Officer (Consultant) & Managing Member
David Bradford, MD - Chief Scientific Advisor (Consultant) & Managing Member
Chris Wakeman - Vice President, Sales and Marketing
John Claude, MS - Director, Engineering
Private - Founders, Company personnel, and Accredited Investors only (details may be made available for inspection to authorized parties under strict restrictions of confidentiality only)
Nocimed is dedicated to its mission to provide disruptive, new and improved diagnostic solutions for measuring chemical signatures of abnormal medical conditions which address significant unmet needs for better managing patients and directing therapies for improved outcomes - in particular in musculoskeletal and pain fields. Nociscan™ is our first investigational product and is being developed as a software suite to interface with existing MR systems to conduct a new application of MR spectropscopy (MRS) to detect chemical signatures of pain in discs of the lower spine, thus supplementing the current regimen of MRI followed by invasive needle-based discogram with additional information to hopefully assist doctors in the future for diagnosing degenerative and painful discs causing chronic, severe discogenic low back pain.
The Company has exclusive, proprietary rights under multiple patent applications pending worldwide. The following are all proprietary trademarks of Nocimed, LLC (all rights reserved):
Chris Wakeman, VP Sales & Marketing